Expanded Access to Venetoclax

Sponsor: AbbVie

Expanded Access
Sponsor score: 60
Inactive

ClinicalTrials ID:NCT03123029

Patient View

This Expanded Access Program provides Venetoclax to eligible participants who cannot join a clinical trial. Pediatric cases are considered individually. Venetoclax is administered orally, and a medical doctor must assess the risk-benefit ratio based on the patient's medical history and program criteria. Availability varies by territory.

Patient Parameters

Program Overview

This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to Venetoclax prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.

Eligibility Criteria

Inclusion Criteria

  • The participant must not be eligible for a venetoclax clinical trial.
  • Pediatric participants may be evaluated on a case by case basis.

Get This Program In Your Inbox

You can sign up and apply your patients for this program.